Porton Pharma Solutions Ltd. (SHE:300363)
15.63
+0.97 (6.62%)
May 20, 2026, 12:34 PM CST
3.17% (1Y)
| Market Cap | 7.95B +6.6% |
| Revenue (ttm) | 3.50B +11.8% |
| Net Income | 128.49M |
| EPS | 0.23 |
| Shares Out | 542.18M |
| PE Ratio | 64.74 |
| Forward PE | 39.62 |
| Dividend | 0.09 (0.61%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 25,202,341 |
| Average Volume | 18,593,983 |
| Open | 15.66 |
| Previous Close | 14.66 |
| Day's Range | 14.66 - 15.70 |
| 52-Week Range | 14.30 - 30.40 |
| Beta | 0.62 |
| RSI | 18.34 |
| Earnings Date | Aug 25, 2026 |